News

Medigene announces participation at six national and international conferences

SHOW RELEASE

Medigene revises collaboration with Mitsui Norin

SHOW RELEASE

Announces target and outlines design for its first clinical trial in TCR cancer immunotherapy

SHOW RELEASE

Medigene publishes its 2016 annual report and outlook for 2017

SHOW RELEASE

Medigene participates at five national and international conferences in February and March 2017

SHOW RELEASE

Medigene announces outlicensing of AAVLP technology

SHOW RELEASE

Medigene participates at four national and international conferences in January 2017

SHOW RELEASE

Medigene AG to be included in TecDAX Index

SHOW RELEASE

Medigene appoints Dr. Thomas Taapken as Chief Financial Officer

SHOW RELEASE

Medigene highlights a new approach for neoantigen-specific TCRs at Neoantigen Summit 2016 in Boston

SHOW RELEASE